Valvular heart disease management guidelines were updated last week by the AHA and the ACC. The last complete version had been published in 2014; therefore many of its recommendations have become obsolete before the latest evidence. The studies that made the FDA approve TAVI for low-risk patients are probably the most important incorporations. They also<a href="https://solaci.org/en/2021/01/07/new-valvular-heart-disease-guidelines-with-key-tavi-and-mitral-regurgitation-updates/" title="Read more" >...</a>
Sapien Valve Keeps Delivering in Jobs for Which It Was Not Designed
We recently published the success of balloon-expandable Sapien valve when used as mitral valve replacement. We now hear about its success as pulmonary valve replacement. Previous experiences with this prosthesis for aortic valve replacement have encouraged many operators to attempt fixing other valves. At first, there were exceptional cases considered compassionate treatments. However, experience has<a href="https://solaci.org/en/2020/12/16/sapien-valve-keeps-delivering-in-jobs-for-which-it-was-not-designed/" title="Read more" >...</a>
Good Evolution of Bicuspid Valves with EVOLUTE or EVOLUTE PRO
Courtesy of Dr. Carlos Fava. TAVR has matured over time and has advanced onto low risk patients, but one of its greatest challenges continues to be bicuspid valve patients. These represent between 1% and 2% of the population and over 20% of young adults requiring surgical valve replacement (SAVR). The study looked at 27,086 patients<a href="https://solaci.org/en/2020/08/28/good-evolution-of-bicuspid-valves-with-evolute-or-evolute-pro/" title="Read more" >...</a>
SAPIEN 3: Good Outcomes in Bicuspids
Courtesy of Dr. Carlos Fava. Bicuspid aortic valves are found in approximately 2% of patients and represent the most frequent cause of aortic stenosis in young adults requiring valve replacement. Though TAVR has advanced significantly, this entity has not yet been included in the different randomized studies. At present, we have data from different reports,<a href="https://solaci.org/en/2020/08/21/sapien-3-good-outcomes-in-bicuspids/" title="Read more" >...</a>
SOLACI-CACI 2021 Preliminary Agenda
Check out the main topics of the upcoming SOLACI-CACI 2021 Congress. Save the Date! Special Session About the COVID-19 Pandemic Managing Cardiovascular disease and Cath Lab during the COVID-19 Pandemic Live Case Transmissions Coronary and Structural cases performed by distinguished international and national operators. Coronary Track Myocardial Infarction, Left Main session, Complex<a href="https://solaci.org/en/2020/06/09/solaci-caci-2021-preliminary-agenda/" title="Read more" >...</a>
Should We Finalize TAVR with Atrial Pacing in Some Patients?
Courtesy of Dr. Carlos Fava. The benefits of transcatheter aortic valve replacement (TAVR) are undoubtedly clear, but implantation is performed near the atrioventricular (AV) node, the bundle of His, and the left bundle branch. Consequently, permanent pacemaker implantation (PPI) after TAVR or surgical aortic valve replacement becomes necessary. While researchers have recently developed strategies to reduce<a href="https://solaci.org/en/2020/06/01/should-we-finalize-tavr-with-atrial-pacing-in-some-patients/" title="Read more" >...</a>
Procedural Rescheduling Criteria in the Pandemic Era
Patients with structural heart disease are at higher risk in the face of the new coronavirus infection due to both advanced age and numerous comorbidities. All variables must be taken into account when deciding whether a patient can wait (so as to minimize the risk of exposure to the virus) or their pathology must be<a href="https://solaci.org/en/2020/04/20/procedural-rescheduling-criteria-in-the-pandemic-era/" title="Read more" >...</a>
IVUS in Left Main Coronary Artery Angioplasty: Luxury or Necessity?
Technique advancements in left main coronary artery angioplasty have turned this procedure into a reasonable alternative to surgery, particularly in patients with a low or intermediate Syntax score and, obviously, those in whom surgery was contraindicated. Results can be credited to a refinement in technique, better drug-eluting stents, better patient selection, and frequent use of<a href="https://solaci.org/en/2020/04/15/ivus-in-left-main-coronary-artery-angioplasty-luxury-or-necessity/" title="Read more" >...</a>
Aortic Valvuloplasty as a Bridge to TAVR: Are We Wasting Our Time?
Doing a balloon aortic valvuloplasty can be a good way to “buy” time before a transcatheter aortic valve replacement (TAVR), according to a registry to be published this week in J Am Coll Cardiol Intv. This study analyzed the database of a whole country to find out the incidence, predictors and outcomes of balloon aortic<a href="https://solaci.org/en/2020/04/13/aortic-valvuloplasty-as-a-bridge-to-tavr-are-we-wasting-our-time/" title="Read more" >...</a>
The Most Read Scientific Articles of March
01- Coronavirus and the Heart: How Should Cardiologists Prepare? As the number of confirmed cases increases throughout the globe, a picture is emerging as to what the direct cardiovascular effects of this pandemic may be. Read more HERE 02- TAVR: Should Transradial Approach be the Second Access Site? Courtesy of Dr. Carlos Fava. One of<a href="https://solaci.org/en/2020/04/08/the-most-read-scientific-articles-of-march/" title="Read more" >...</a>